Arginine silicate inositol for improving cognitive function
AssigneeNutrition21, LLC
InventorJames R. Komorowski
Life of this patent
Estimating the term…
Loading patent…
AssigneeNutrition21, LLC
InventorJames R. Komorowski
Estimating the term…
The present disclosure relates to the use of inositol-stabilized arginine (“ASI”) for improving cognition. For example, in some implementations, methods include administering an amount of ASI effective to improve cognition in humans. Some embodiments include the use of ASI for improving mental focus and/or attention span. For example, in some implementations, methods include administering an amount of ASI effective to improve mental focus and/or attention span in humans. Some embodiments include the use of ASI for treating and/or preventing cognitive disorders. Cognitive disorders may include stroke, anoxic brain injury, traumatic brain injury, dementia, Alzheimer's disease, Parkinson's disease, MCI, and age-related memory loss, attention deficit hyperactivity disorder (“ADHD”), and other learning disabilities.
1-20. (canceled)
A method for improving mood in a subject in need thereof, the method comprising administering to the subject an effective amount of inositol-stabilized arginine silicate.
A method of improving energy in a subject in need thereof, the method comprising administering to the subject an effective amount of inositol-stabilized arginine silicate.
Dependencies are inferred from the claim text.